Fluconazole-resistant Candida albicans after long-term suppressive therapy

Arch Intern Med. 1993 May 10;153(9):1122-4.


Candida albicans is generally considered to be susceptible, in vivo, to fluconazole. In the population infected with human immunodeficiency virus, recurrent bouts of oral and esophageal candidiasis have led to increasing use of fluconazole for long-term prophylaxis. With prolonged therapy, the issue of developing resistance emerges. We report a case of fluconazole-resistant C albicans esophagitis that developed after fluconazole was used for more than 600 days.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / prevention & control*
  • Adult
  • Candida albicans / drug effects*
  • Candidiasis / microbiology
  • Candidiasis, Oral / prevention & control*
  • Drug Resistance
  • Esophageal Diseases / microbiology
  • Fluconazole / pharmacology*
  • Fluconazole / therapeutic use
  • Humans
  • Male


  • Fluconazole